Hyperion Therapeutics Inc. $28.82
|Trade Time:||Mar 07 08:10 PM Eastern Daylight Time|
|Change:||-0.18 (-0.62 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get HPTX Trend Analysis - it has outperformed the S&P 500 by 11%
|Date||Name||Title||Volume||Trade Price||Holding Change|
|3/04/2014||HEALY JAMES||Senior Executive Officer||-23,625||$30.02||-100.00%|
|1/14/2014||Nash Christine A||SVP & Chief Commercial Officer||-1,100||$24.01||-17.75%|
|1/14/2014||Nash Christine A||SVP & Chief Commercial Officer||6,100||$1.28||6,224.49%|
|1/10/2014||Nash Christine A||SVP & Chief Commercial Officer||-8,900||$24.10||-98.91%|
|1/10/2014||Nash Christine A||SVP & Chief Commercial Officer||8,900||$1.28||9,081.63%|
HPTX Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!